Confined CHA-HCR system for sensitive and specific detection of ANXA2 mRNA in adenomyosis tissues

Lin G, Guan Lin, Lin Guan, Zhenna Wang, Wang Z, Li Q, Qiulei Li, Jia-Ming Zhang, Zhang J, Jinna Zhang, Guo S, Sang Guo, Huo Xu, Lin S, Shunhe Lin, Xie X, Xi Xie
Journal of pharmaceutical and biomedical analysis · 2025 · vol. 257 , pp. 116708 · doi:10.1016/j.jpba.2025.116708 · PMID:39879821 · W4406834642
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-11 ⓘ

This study developed a confined CHA-HCR system using cholesterol-modified probes to achieve sensitive and specific detection of ANXA2 mRNA in clinical tissue samples, differentiating expression levels between adenomyosis and leiomyoma.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Isothermal, enzyme-free amplification techniques, such as the hybridization chain reaction (HCR) and catalytic hairpin assembly (CHA), have gained significant attention for mRNA analysis. Despite their potential, these methods still face challenges, including false positives and low amplification efficiency. To overcome these limitations, we have developed a confined catalytic hairpin assembly and hybridization chain reaction (CHA-HCR) system that utilizes cholesterol-modified hairpin probes to enhance the sensitivity and specificity of mRNA detection. This system integrates cholesterol-modified hairpin probes (CHA probes) with hybridization chain reaction probes (HCR probes), leveraging hydrophobicity-mediated assembly to create a robust biosensing platform. The CHA-HCR system initiates a complex formation with the target mRNA, triggering a cascade of hybridization events that amplify the fluorescence signal. Employing ANXA2 mRNA as a model system, our results reveal that the CHA-HCR system achieves a detection limit (LOD) of 8.7 pM and offers high selectivity, effectively distinguishing ANXA2 mRNA from similar RNAs with single-base mismatches. Additionally, the CHA-HCR probes demonstrate stable detection performance in complex environments and exhibit excellent sensing capabilities in clinical tissue samples, successfully differentiating ANXA2 mRNA expression between leiomyoma and adenomyosis patient tissues. This study introduces a promising approach for the early diagnosis and monitoring of diseases associated with mRNA, potentially contributing to improved clinical outcomes and personalized treatment strategies.

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis Adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (25)

SciLite annotations

chemicals 2
cholesterol cholesterol

Source provenance

europepmc
last seen: 2026-08-01T06:07:04.264727+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-08-01T06:04:18.728514+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
unpaywall
last seen: 2026-06-06T02:00:05.402940+00:00
License: CC0 · commercial use OK